Literature DB >> 17021603

Hydroxyproline ingestion and urinary oxalate and glycolate excretion.

J Knight1, J Jiang, D G Assimos, R P Holmes.   

Abstract

Endogenous synthesis of oxalate is an important contributor to calcium oxalate stone formation and renal impairment associated with primary hyperoxaluria. Although the principal precursor of oxalate is believed to be glyoxylate, pathways in humans resulting in glyoxylate synthesis are not well defined. Hydroxyproline, a component amino acid of collagen, is a potential glyoxylate precursor. We have investigated the contribution of dietary hydroxyproline derived from gelatin to urinary oxalate and glycolate excretion. Responses to the ingestion of 30 g of gelatin or whey protein were compared on controlled oxalate diets. The time course of metabolism of a 10 g gelatin load was determined as well as the response to varying gelatin loads. Urinary glycolate excretion was 5.3-fold higher on the gelatin diet compared to the whey diet and urinary oxalate excretion was 43% higher. Significant changes in plasma hydroxyproline and urinary oxalate and glycolate were observed with 5 and 10 g gelatin loads, but not 1 and 2 g loads. Extrapolation of these results to daily anticipated collagen turnover and hydroxyproline intake suggests that hydroxyproline metabolism contributes 20-50% of glycolate excreted in urine and 5-20% of urinary oxalate derived from endogenous synthesis. Our results also revealed that the kidney absorbs significant quantities of hydroxyproline and glycolate, and their metabolism to oxalate in this tissue warrants further consideration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021603      PMCID: PMC2268952          DOI: 10.1038/sj.ki.5001906

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  Contribution of dietary oxalate to urinary oxalate excretion.

Authors:  R P Holmes; H O Goodman; D G Assimos
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

2.  Estimation of the oxalate content of foods and daily oxalate intake.

Authors:  R P Holmes; M Kennedy
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

3.  Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.

Authors:  David A Bushinsky; John R Asplin; Marc D Grynpas; Andrew P Evan; Walter R Parker; Kristen M Alexander; Fredric L Coe
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

4.  Fluorometric determination of N-terminal prolyl dipeptides, proline and hydroxyproline in human serum by pre-column high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsufonyl chloride.

Authors:  H Inoue; H Iguch; A Kouno; Y Tsuruta
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-06-15

Review 5.  Urinary excretion of hydroxyproline in health and disease.

Authors:  K I Kivirikko
Journal:  Int Rev Connect Tissue Res       Date:  1970

6.  Dietary oxalate loads and renal oxalate handling.

Authors:  Ross P Holmes; Walter T Ambrosius; Dean G Assimos
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

7.  Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria.

Authors:  John Knight; Ross P Holmes
Journal:  Am J Nephrol       Date:  2005-04-21       Impact factor: 3.754

8.  Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.

Authors:  S R Khan; P A Glenton; K J Byer
Journal:  Kidney Int       Date:  2006-07-19       Impact factor: 10.612

9.  Control of oxalate formation from L-hydroxyproline in liver mitochondria.

Authors:  Tatsuya Takayama; Kimio Fujita; Kazuo Suzuki; Michiko Sakaguchi; Michio Fujie; Erina Nagai; Shinya Watanabe; Arata Ichiyama; Yoshihide Ogawa
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

10.  A porcine model of calcium oxalate kidney stone disease.

Authors:  Neil S Mandel; James D Henderson; Linda Y Hung; David F Wille; John H Wiessner
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

View more
  61 in total

1.  Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.

Authors:  Kristin J Bergsland; Anna L Zisman; John R Asplin; Elaine M Worcester; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-01

2.  4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.

Authors:  Travis J Riedel; John Knight; Michael S Murray; Dawn S Milliner; Ross P Holmes; W Todd Lowther
Journal:  Biochim Biophys Acta       Date:  2012-07-05

3.  Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.

Authors:  Ruth Belostotsky; James Jonathon Pitt; Yaacov Frishberg
Journal:  J Mol Med (Berl)       Date:  2012-06-24       Impact factor: 4.599

4.  Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.

Authors:  Aaron W Miller; David Choy; Kristina L Penniston; Dirk Lange
Journal:  Kidney Int       Date:  2019-02-28       Impact factor: 10.612

5.  Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate.

Authors:  John Knight; Dean G Assimos; Michael F Callahan; Ross P Holmes
Journal:  Metabolism       Date:  2010-10-30       Impact factor: 8.694

6.  Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.

Authors:  Ada Ventzke; Markus Feldkötter; Andrew Wei; Jutta Becker; Bodo B Beck; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2017-07-15       Impact factor: 3.714

7.  Vitamin B6 deficiency augments endogenous oxalogenesis after intravenous L-hydroxyproline loading in rats.

Authors:  Y Ogawa; R Z Hossain; T Ogawa; K Yamakawa; H Yonou; Y Oshiro; S Hokama; M Morozumi; A Uchida; K Sugaya
Journal:  Urol Res       Date:  2007-01-03

8.  Response of germ-free mice to colonization with O. formigenes and altered Schaedler flora.

Authors:  Xingsheng Li; Melissa L Ellis; Alexander E Dowell; Ranjit Kumar; Casey D Morrow; Trenton R Schoeb; John Knight
Journal:  Appl Environ Microbiol       Date:  2016-09-23       Impact factor: 4.792

9.  A conserved active site tyrosine residue of proline dehydrogenase helps enforce the preference for proline over hydroxyproline as the substrate.

Authors:  Elizabeth L Ostrander; John D Larson; Jonathan P Schuermann; John J Tanner
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

Review 10.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.